Als header
Latest Articles

Antibody-based lung fibrosis therapy gets a redesign

AdAlta has announced major improvements to the design of its preclinical therapy for lung fibrosis which have enhanced the drug's potency and extended its half-life.

Life Scientist 19 April, 2018

New initiative to propel MTP SMEs

The SME Strategic Innovation Initiative will help Australian medical technology and pharmaceutical companies better prepare themselves to engage with multinational companies.

Life Scientist 18 April, 2018

Personalised cancer vaccine underway at UQ

Researchers have developed a vaccine delivery technology that enables treatment to be tailored for different cancers, improving the precision of cancer immunotherapy.

Life Scientist 17 April, 2018

Australia's biotech boom to continue

The Australian life sciences and biotech industry is witnessing a resurgence in activity, which is expected to continue over the next 12 months.

Life Scientist 16 April, 2018

Bad immune cells can turn good

Scientists have discovered that cells once thought to be useful, and even a liability, could be important tools in the fight against disease — including the...

Life Scientist 13 April, 2018

Biotechnology
Australia's biotech boom to continue

Australia's biotech boom to continue

The Australian life sciences and biotech industry is witnessing a resurgence in activity, which is expected to continue over the next 12 months.

Article 16 April, 2018
Health & Medical
Drug delays disability in secondary progressive MS

Drug delays disability in secondary progressive MS

A new drug is said to slow the progression of disability in secondary progressive multiple sclerosis (MS), according to a double-blind, randomised,...

Article 27 March, 2018
Life Sciences
Bad immune cells can turn good

Bad immune cells can turn good

Scientists have discovered that cells once thought to be useful, and even a liability, could be important tools in the fight against disease...

Article 13 April, 2018
Molecular Biology
CRISPR gene-editing tool targets RNA, tackles dementia

CRISPR gene-editing tool targets RNA, tackles dementia

Scientists have used CRISPR gene-editing technology to target RNA — as opposed to DNA — and in the process corrected a protein...

Article 19 March, 2018
Lab Technology
Award-winning digital innovations for the health sector

Award-winning digital innovations for the health sector

The winning entries in the 2015 national iAwards have brought a range of benefits to a variety of sectors — with the health sector being no...

Article 09 September, 2015
  • All content Copyright © 2018 Westwick-Farrow Pty Ltd